MedPath

An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study

Conditions
Anemia
Arthroplasty, Replacement, Knee
Arthroplasty, Replacement, Hip
Interventions
Drug: Iron-III Isomaltoside 1000
Other: Standard Care
Registration Number
NCT02385383
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

This observational study follows a cohort of patients scheduled for elective hip- or knee surgery but has preoperative anemia and are treated with Intravenous (IV) iron prior to surgery according to a recently introduced standardized treatment protocol at 6 high-volume surgical centres.

Detailed Description

Patients presenting with preoperative anaemia prior to hip and knee arthroplasty has a high risk of receiving allogeneic blood transfusion and anaemia has been associated with increased postoperative morbidity and mortality. While IV-iron administration may raise Hb prior to surgery, existing guidelines for addressing and treating preoperative anaemia is not widely implemented for patients scheduled for elective total joint arthroplasty (TJA) in Denmark. In addition, causes of preoperative anaemia and the efficacy of preoperative IV-iron administration has not been sufficiently evaluated in elective TJA.

This is a observational follow-up study among 6 Danish high volume surgical centres that has recently introduced a standardized anaemia screening and treatment protocol for patients with preoperative anaemia scheduled for total hip- or knee arthroplasty.

Patients with iron deficiency anaemia or anaemia of chronic inflammation receive infusion of IV-iron (Monofer) 4 weeks prior to surgery as a part of the standard operating procedure on the department.

The aim of this follow up study is to evaluate changes in Haemoglobin concentration, transfusion rate and postoperative morbidity in this cohort.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Age > 18 years
  • Scheduled for elective primary hip- or knee arthroplasty
  • Preoperative hemoglobin < 13 g/dl (males) or < 12 g/dl (females)
  • Included in the departments treatment protocol for preoperative anemia
Exclusion Criteria
  • Cronic transfusion need
  • Not able to give consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with preoperative anemia following treatment protocolIron-III Isomaltoside 1000Patients with preoperative anemia according to the WHO definition and treated with a protocol of Iitravenous iron prior to surgery
Patients with preoperative anemia - Historical controlStandard CareCohort of preoperative anemic patients from the Lundbeckcentre Database. Serving as a historical control
Primary Outcome Measures
NameTimeMethod
Transfusion RateFrom date of admission to date of discharge (up to 30 days)

Blood transfusion (yes/no) during the entire hospital stay

Secondary Outcome Measures
NameTimeMethod
Classification of preoperative anemia4 weeks prior to surgery (baseline)
Change in hemoglobin concentrationFrom date of preoperative blood sampling (baseline) to date of admission (Up to 4 weeks)

The change in Hb from the time of preoperative blood sampling to Hb sampled on the date of admission

No. of red blood cell units administered per patientFrom date of admission to date of discharge (up to 30 days)

No of blood units administered during the entire hospital stay

Length of Hospital stayFrom date of admission to Date of discharge (up to 30 days)
Postoperative complications and readmissionsFrom date of surgery up to 90 days after surgery

Trial Locations

Locations (6)

Bisbebjerg Hospital, Dept. of orthopedic surgery

🇩🇰

Copenhagen NV, Denmark

Farsø Sygehus

🇩🇰

Farsø, Denmark

Gentofte Hospital, Dept. of orthopedic surgery

🇩🇰

Hellerup, Denmark

Hvidovre Hospital, Department of orthopaedic surgery

🇩🇰

Hvidovre, Denmark

Vejle Sygehus, Dept. of orthopedic surgery

🇩🇰

Vejle, Denmark

Viborg Sygehus, Dept. of orthopedic surgery

🇩🇰

Viborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath